Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720806 · ClinicalTrials.gov registry record · NA
Weight Bearing Status Post-hip Arthroscopy
A NA study of Acetabular Labral Tear and Hip Impingement Syndrome, sponsored by University of Pittsburgh.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05720806: Active NA study of Acetabular Labral Tear and Hip Impingement Syndrome, sponsored by University of Pittsburgh.
NCT05720806 is a NA study of Acetabular Labral Tear and Hip Impingement Syndrome that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05720806, a NA study of Acetabular Labral Tear and Hip Impingement Syndrome, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being proposed to examine weight bearing precautions following hip arthroscopic labral repair, femoroplasty, and capsular closure. Standard post operative protocols limit weight bearing for 2-6 weeks depending on individual surgeons. Cadaveric studies demonstrate that minimal force during weight bearing is distributed through labrum. Therefore, progressing weight bearing earlier in these patients post operatively may help progress faster and improve outcomes. Data collected will include demographic information, radiological data, operative procedures and PRO data.
Primary Outcome
Scoring ranges from 0-100 * each question is rated from 0-100 and final score is the mean of all questions answered by subject * higher scoring indicating higher quality of life due to hip function
Conditions Studied
Interventions
- OTHER Weight Bearing as tolerated (WBAT) immediately following surgery.
- OTHER Flat foot weight bearing (FFWB) immediately following surgery
Study Locations (1)
Pennsylvania
- UPMC Hip Preservation Program - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What the registry record for NCT05720806 still lists
NCT05720806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Acetabular Labral Tear appearing as the primary indexed condition, and to 2 interventions - of which Weight Bearing as tolerated (WBAT) immediately following surgery. is the first listed.
NCT05720806 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05720806 about?
NCT05720806 is a clinical study titled "Weight Bearing Status Post-hip Arthroscopy". This study is being proposed to examine weight bearing precautions following hip arthroscopic labral repair, femoroplasty, and capsular closure. Standard post operative protocols limit weight bearing for 2-6 weeks depending on individual surgeons. Cadaveric studies demonstrate that minimal force dur...
What is the current status of trial NCT05720806?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-05-01. Estimated completion is 2026-03-01.
What conditions does trial NCT05720806 study?
This clinical trial studies the following conditions: Acetabular Labral Tear, Hip Impingement Syndrome.
What interventions are being tested in trial NCT05720806?
The interventions under investigation include: Weight Bearing as tolerated (WBAT) immediately following surgery. (OTHER), Flat foot weight bearing (FFWB) immediately following surgery (OTHER).
Who is sponsoring clinical trial NCT05720806?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05720806 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acetabular Labral Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05720806's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI